Drug Trial Radar · NCT03282227
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
Last checked: Nov 20, 2026Latest source record: Aug 19, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
342
Actual
Start
Nov 7, 2017
Primary completion
May 17, 2019
Study completion May 17, 2019
Sponsor
- Lead sponsor
- Zosano Pharma CorporationIndustry
- Sponsor type
- Industry
- First posted
- Sep 13, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an open-label, twelve-month safety study. There is a screening period followed by a run-in period to record migraine activity. Qualified subjects will receive study medication for up to twelve months for the treatment of multiple migraine attacks. Using the electronic diary (eDiary) to confirm they are experiencing a qualified migraine, subjects will self-administer the patches and respond to questions in the eDiary post treatment administration.
Conditions
- Migraine
Interventions
M207 Microneedle SystemDrug
M207 Microneedle System 3.8 mg
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Subjects With Any Treatment-emergent Adverse Events (TEAE) Over 12 MonthsTime frame: 0 to 12 months
Locations
31 sites in 1 country. Site status is shown where the registry gives one.
Achieve Clinical Research
Birmingham, Alabama
Elite Clinical Studies
Phoenix, Arizona
Downtown L.A. Research Center
Los Angeles, California
Stanford University Medical Center
Palo Alto, California
Allergy Asthma Associates of Santa Clara Valley Research Center
San Jose, California
California Medical Clinic for Headache
Santa Monica, California
Empire Clinical Research
Upland, California
Colorado Allergy Asthma Centers
Denver, Colorado
Harmony Medical Research Institute
Hialeah, Florida
Advanced Clinical Research
Meridian, Idaho
DelRicht Research
New Orleans, Louisiana
Boston Clinical Trials
Boston, Massachusetts
MedVadis Research Corporation
Watertown, Massachusetts
Michigan Headache and Neurological Institute
Ann Arbor, Michigan
Clinical Research Institute
Minneapolis, Minnesota
Clinical Research Institute
Plymouth, Minnesota
StudyMetrix Research LLC
City of Saint Peters, Missouri
Clinvest Research
Springfield, Missouri
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire
Albuquerque Clinical Trials
Albuquerque, New Mexico
Rochester Clinical Research
Rochester, New York
Peters Medical Research
High Point, North Carolina
North Carolina Clinical Research
Raleigh, North Carolina
Raleigh Medical Group PMG Research
Raleigh, North Carolina
Lillestol Research
Fargo, North Dakota
Thomas Jefferson University
Philadelphia, Pennsylvania
Primary Care Associates/Radiant Research
Anderson, South Carolina
Coastal Carolina Research Center
Mt. Pleasant, South Carolina
FutureSearch Trials of Neurology
Austin, Texas
University of Texas Southwestern Medical Center - Neurology Clinic
Dallas, Texas
Central Texas Health Research
New Braunfels, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.